Copyright
©The Author(s) 2020.
World J Clin Cases. Sep 6, 2020; 8(17): 3786-3796
Published online Sep 6, 2020. doi: 10.12998/wjcc.v8.i17.3786
Published online Sep 6, 2020. doi: 10.12998/wjcc.v8.i17.3786
Figure 1 Flow chart of the study.
FMT: Fecal microbiota transplantation; TET: Transendoscopic enteral tubing.
Figure 2 Approaches to learn about fecal microbiota transplantation and transendoscopic enteral tubing for the first time.
A, B: All respondents’ approaches to primarily knowing about fecal microbiota transplantation (A) and transendoscopic enteral tubing (B) in patients without experience of fecal microbiota transplantation.
Figure 3 Reasons for supporting fecal microbiota transplantation (A) and not supporting fecal microbiota transplantation (B).
Figure 4 Optimal methods of undergoing fecal microbiota transplantation.
A: The preferred delivery of Crohn’s disease patients with and without experience of fecal microbiota transplantation; B: The preferred delivery way of ulcerative colitis patients with and without experience of fecal microbiota transplantation. FMT: Fecal microbiota transplantation; TET: Transendoscopic enteral tubing.
- Citation: Zhong M, Sun Y, Wang HG, Marcella C, Cui BT, Miao YL, Zhang FM. Awareness and attitude of fecal microbiota transplantation through transendoscopic enteral tubing among inflammatory bowel disease patients. World J Clin Cases 2020; 8(17): 3786-3796
- URL: https://www.wjgnet.com/2307-8960/full/v8/i17/3786.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v8.i17.3786